Biohaven Ltd.BHVNNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+13.3%
5Y CAGR+45.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+13.3%/yr
Annual compound
5Y CAGR
+45.2%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $635.07M | -20.2% |
| 2024 | $795.87M | +113.2% |
| 2023 | $373.28M | -14.6% |
| 2022 | $437.07M | +140.8% |
| 2021 | $181.49M | +84.3% |
| 2020 | $98.46M | -71.4% |
| 2019 | $344.67M | - |